A case of thrombotic thrombocytopenic purpura associated with bupropion

International Journal of Clinical Pharmacology and Therapeutics

Volumn 51, Issue 3, 2013, Pages 224-227

  Altintas, Neriman Defne ^a   Izdes, Seval ^a   Yucel, Sibel ^b   Suher, Murat ^b   Dilek, Imdat ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Department of Anesthesiology and Reanimation ^*  (Turkey)

Author keywords

Bupropion; Plasma exchange; Thrombotic thrombocytopenic purpura

Indexed keywords

AMFEBUTAMONE; BILIRUBIN; CREATININE; DIAZEPAM; HEMOGLOBIN; LACTATE DEHYDROGENASE; PREDNISOLONE; UREA;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; CONFUSION; CONVALESCENCE; DIARRHEA; DISEASE ASSOCIATION; DRUG WITHDRAWAL; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NARANJO ADVERSE DRUG REACTION PROBABILITY SCALE; PLASMAPHERESIS; RESPIRATORY TRACT INTUBATION; SMOKING CESSATION; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TOBACCO DEPENDENCE; TONIC CLONIC SEIZURE; UNCONSCIOUSNESS;

ADAM PROTEINS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; HUMANS; MALE; MIDDLE AGED; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 84874745374     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201865     Document Type: Article

References (8)

1. Patel DR, Feucht C, Reid L, Patel ND. Pharmacologic agents for smoking cessation: a clinical review. Clin Pharmacol. 2010; 2: 17-29. CrossRef PubMed
2. Fix BV, Hyland A, Rivard C, McNeill A, Fong GT, Borland R, Hammond D, Cummings KM. Usage patterns of stop smoking medications in Australia, Canada, the United Kingdom, and the United States: findings from the 2006-2008 International Tobacco Control (ITC) Four Country Survey. Int J Environ Res Public Health. 2011; 8: 222-233. CrossRef PubMed
3. http://www.iegm.gov.tr/Folders/KubKT/Yeni%20%C4%B0la%C3%A7, %20Ara%20%C3%9Cr% C3%BCn%20%C5%9Eube%20M%C3%BCd%C3%BCrl%C3%BC%C4%9F%C3%BC/ Wellbutrin- XL-150mg-KUB-2089d5d.pdf (last accessed on 02.08.2012).
4. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006; 354: 1927-1935. CrossRef PubMed
5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30: 239-245. CrossRef PubMed
6. George JN. Evaluation and management of patients with thrombotic thrombocytopenic purpura. J Intensive Care Med. 2007; 22: 82-91. CrossRef PubMed
7. Beyens MN, Guy C, Mounier G, Laporte S, Ollagnier M. Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. Drug Saf. 2008; 31: 1017-1026. CrossRef PubMed
8. Mele L, Voso MT, Fianchi L, Leone G, Pagano L. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after bupropion treatment for smoking cessation. Blood Coagul Fibrinolysis. 2003; 14: 77-78. CrossRef PubMed